In addition to the genetic causes of NF-κB dysregulation in CLL and MM, it is now appreciated that the tumor microenvironment plays a critical role in modulating NF-κB activity in these diseases. This evidence concerns the gene NFKB1 and B-cell chronic lymphocytic leukemia.